Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Recruiting · NCT06654193 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT06654193 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Texas Health Science Center at Houston (UTHealth Houston) | Houston | United States | 1 |